Docusate Sodium is available over the counter and is indicated for constipation in adults and children greater than six years of age.
Introduction
Taro Pharmaceuticals Canada Inc., in consultation with Health Canada, is voluntarily recalling "Docusate Sodium Capsules USP, 100 mg" (Lot # 31040225) from the Canadian market due to possible contamination with the bacterial organism cronobacter (enterobacter) sakazakii.
Issue
Cronobacter (enterobacter) sakazakii is a bacteria that is a rare cause of serious or life-threatening infections, including meningitis and bloodstream infections, particularly in premature infants. Other vulnerable individuals include the elderly and those with weakened immune systems.
Who is affected
Canadians who have purchased or used "Docusate Sodium Capsules USP, 100 mg" (Lot # 31040225)
What you should do
Consumers should speak to their healthcare practitioner if they or any of their family members have used this product.
Taro Pharmaceuticals Canada Inc. is advising consumers to discontinue use of Docusate Sodium Capsules USP, 100 mg" (Lot # 31040225).
Report any adverse reaction potentially related to these products to Health Canada (see below).
Media and consumers should contact Taro Pharmaceuticals Canada Inc. at 1-800-268-1975 for more information.
Background
Taro Pharmaceuticals Canada Inc. has discontinued distribution of "Docusate Sodium Capsules USP, 100 mg" (Lot # 31040225) and is following-up with their wholesalers and retailers.
What Health Canada is doing
Health Canada is monitoring the recall of "Docusate Sodium Capsules USP, 100 mg" (Lot # 31040225) from the Canadian market. Should any new information be identified, Health Canada will continue to provide an update to Canadians.
It is important to note that to date, Health Canada has not received any reports of adverse reactions in Canada associated with the use of Taro Pharmaceuticals Canada Inc's. Docusate Sodium Capsules USP, 100 mg and contamination.
Report health or safety concerns
To report a suspected adverse reaction to these or other health products, please contact Heath Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send to us using one of these methods: